Bone remodeling serum markers in children with systemic lupus erythematosus
Abstract Indroduction SLE is an autoimmune multisystem disease. Glucocorticoid is an irreplaceable medication for SLE. Glucocorticoid and inflammatory mediators impact bone remodeling by OPG/RANKL/RANK signal system, which could lead to osteoporosis. Our aim is to detect the expression of RANKL/OPG...
Saved in:
Main Authors: | Sheng Hao (Author), Jing Zhang (Author), Bingxue Huang (Author), Dan Feng (Author), Xiaoling Niu (Author), Wenyan Huang (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum markers thrombophilia in pregnant women with Systemic Lupus Erythematosus
by: Vanessa Marcon de Oliveira, et al. -
The rapid inhibition of B-cell activation markers by belimumab was associated with disease control in systemic lupus erythematosus patients
by: Jing Wang, et al.
Published: (2023) -
Skin lesions in lupus erythematosus: A marker of systemic involvement
by: Nilay Kanti Das, et al.
Published: (2011) -
BONE REMODELING IN NORM AND IN PRIMARY OSTEOPOROSIS: THE SIGNIFICANCE OF BONE REMODELING MARKERS
by: G. M. Nurullina, et al.
Published: (2018) -
Chronic cutaneous lupus erythematosus with systemic symptoms or systemic lupus erythematosus?
by: Suresh K. Malhotra, et al.
Published: (2016)